Core Viewpoint - Haiprime is a leading multinational pharmaceutical company with a focus on heparin, biopharmaceutical CDMO, and innovative drug development, benefiting from the depreciation of the RMB and a strong overseas revenue stream [2][3]. Company Overview - Established in 1998 in Shenzhen, Haiprime operates with A+H dual financing platforms and aims to provide high-quality, safe, and effective drugs and services globally [2]. - The main business segments include heparin industry chain, biopharmaceutical CDMO, and innovative drug investment, development, and commercialization [2][7]. - As of June 30, 2025, Haiprime reported a revenue of 2.817 billion yuan, a year-on-year decrease of 0.71%, and a net profit of 422 million yuan, down 36.44% year-on-year [7]. Financial Performance - The company’s overseas revenue accounted for 93.04% of total revenue, benefiting from the depreciation of the RMB [3]. - The revenue composition includes 63.06% from formulations, 18.59% from CDMO, 16.05% from heparin sodium and low molecular weight heparin raw materials, and 2.30% from other sources [7]. - Cumulative cash dividends since the A-share listing amount to 4.21 billion yuan, with 514 million yuan distributed over the past three years [8]. Market Activity - On October 27, Haiprime's stock rose by 0.84%, with a trading volume of 46.599 million yuan and a market capitalization of 17.622 billion yuan [1]. - The stock has seen a net inflow of 2.6047 million yuan from major investors today, indicating a slight increase in interest [4]. Technical Analysis - The average trading cost of the stock is 11.56 yuan, with the current price fluctuating between resistance at 12.80 yuan and support at 11.53 yuan, suggesting potential for range trading [6].

Core Viewpoint - The company, Ningbo Jialian Technology Co., Ltd., is experiencing growth in its stock price and has a significant overseas revenue share, benefiting from the depreciation of the RMB and the expansion of cross-border e-commerce [1][3]. Company Overview - Ningbo Jialian Technology specializes in the research, production, and sales of plastic products, biodegradable products, and plant fiber products, with a revenue composition of 84.41% from plastic products, 14.25% from biodegradable products, and 1.34% from other sources [7]. - The company was established on August 7, 2009, and went public on December 9, 2021 [7]. Financial Performance - For the first half of 2025, the company achieved a revenue of 1.123 billion yuan, representing a year-on-year growth of 5.26%. However, the net profit attributable to the parent company was a loss of 64.67 million yuan, a decrease of 204.81% compared to the previous year [8]. - The company has distributed a total of 98.4 million yuan in dividends since its A-share listing, with 74.4 million yuan distributed over the past three years [9]. Market Position and Strategy - The company has a strong focus on PLA material research and application, particularly in the consumer-grade FDM materials and products sector, with a broad application potential in industrial design, education, toys, and medical fields [2]. - As of June 30, the company had 5,906 shareholders, an increase of 3.72%, with an average of 22,811 circulating shares per shareholder, up by 34.95% [8]. International Operations - The company’s overseas revenue accounted for 55.43% of total revenue, benefiting from the depreciation of the RMB. The main export markets include North America, Europe, and Oceania, with a focus on large supermarkets and chain restaurants [3]. - The Thai factory serves as a key overseas production capacity node, with multiple production lines for 3D printing materials, plastic dining utensils, and plant fiber products gradually entering production [3].

Core Viewpoint - The company, Zhejiang Wandekai Fluid Equipment Technology Co., Ltd., is experiencing a positive impact from the depreciation of the RMB and is recognized as a "specialized, refined, distinctive, and innovative" enterprise, which enhances its competitiveness in the market [2][3]. Company Overview - Zhejiang Wandekai is located in Donggang Village, Longxi Town, Yuhuan City, Zhejiang Province, and was established on October 31, 2016. It was listed on September 19, 2022. The main business involves the design, development, production, and sales of plumbing equipment [7]. - The company's revenue composition includes valves (57.70%), fittings (40.79%), and other products (1.51%) [7]. - As of June 30, the number of shareholders increased to 11,000, with an average of 2,280 circulating shares per person, a decrease of 1.62% from the previous period [7]. Financial Performance - For the first half of 2025, the company achieved a revenue of 414 million yuan, a year-on-year decrease of 7.29%. The net profit attributable to the parent company was 60.28 million yuan, down 16.92% year-on-year [7]. - The company has distributed a total of 120 million yuan in dividends since its A-share listing [8]. Market Position and Trends - The company benefits from the "common prosperity demonstration zone" and the depreciation of the RMB, which supports its overseas revenue, accounting for 82.39% of total revenue [2][3]. - Wandekai is recognized as a national-level "specialized, refined, distinctive, and innovative" small giant enterprise, which signifies its strong innovation capabilities and high market share in niche markets [3]. Technical Analysis - The average trading cost of the stock is 30.56 yuan, with the current price near a support level of 30.99 yuan. A drop below this support level may trigger a downward trend [6].

Core Viewpoint - The company, Wuhan LianTe Technology Co., Ltd., has shown significant growth in its stock performance and is benefiting from trends in optical communication, 5G, and data centers, alongside the depreciation of the Chinese yuan [1][2]. Company Overview - Wuhan LianTe Technology was established on October 28, 2011, and went public on September 13, 2022. The company specializes in the research, production, and sales of optical communication transceiver modules [7]. - The company's main revenue sources include 10G and above optical modules (92.72%), below 10G optical modules (5.57%), and material sales and leasing (1.71%) [7]. Financial Performance - For the first half of 2025, the company achieved a revenue of 504 million yuan, representing a year-on-year growth of 15.43%. The net profit attributable to the parent company was 34.81 million yuan, up 14.02% year-on-year [8]. - The company has distributed a total of 46.85 million yuan in dividends since its A-share listing [9]. Market Position and Trends - The company has developed core capabilities in optical chip integration, high-speed optical devices, and high-speed optical module design and production. It is currently working on 800G optical modules and technologies required for next-generation products [2][3]. - The optical module market is experiencing rapid growth, particularly in the data communication sector, which has surpassed the telecom market to become the largest market for optical modules [2]. Investment Highlights - The company benefits from a low-power design technology for optical modules, which significantly reduces power consumption, providing a competitive edge in 5G communication and data center applications [2]. - As of the latest report, 89.07% of the company's revenue comes from overseas markets, which is positively impacted by the depreciation of the yuan [2].

Core Viewpoint - The company, Meixin Technology, is benefiting from the depreciation of the RMB and its significant overseas revenue, which accounts for 97.08% of its total revenue [2]. Company Overview - Meixin Technology Co., Ltd. is located in Huizhou, Guangdong Province, and was established on June 16, 2004. It was listed on March 13, 2024. The company primarily engages in the research, production, and sales of wood-plastic composite materials and products [3][7]. - The main revenue composition includes wall panels (55.37%), outdoor flooring (44.17%), and other (0.46%) [7]. - As of September 30, the number of shareholders is 6,960, a decrease of 2.77% from the previous period, while the average circulating shares per person increased by 2.84% to 10,540 shares [7]. Financial Performance - For the period from January to September 2025, Meixin Technology achieved a revenue of 672 million yuan, representing a year-on-year growth of 4.39%. However, the net profit attributable to the parent company was 28.40 million yuan, a decrease of 31.53% year-on-year [7]. Market Activity - On October 24, the stock price of Meixin Technology increased by 0.10%, with a trading volume of 26.86 million yuan and a turnover rate of 1.79%. The total market capitalization is 2.427 billion yuan [1]. - The stock has seen a net outflow of 1.73 million yuan from major funds today, with a ranking of 49 out of 76 in its industry, indicating a reduction in major fund positions for three consecutive days [4][5]. Technical Analysis - The average trading cost of the stock is 20.48 yuan, with recent accumulation activity noted, although the strength of this accumulation is weak. The current stock price is near a resistance level of 20.81 yuan, suggesting a potential for a pullback unless this resistance is broken, which could lead to an upward trend [6].

Core Viewpoint - ST诺泰 has shown a positive market performance with a 2.32% increase in stock price, reaching a total market capitalization of 12.52 billion [1] Group 1: Business Overview - The company specializes in custom products, primarily in the CDMO (Contract Development and Manufacturing Organization) sector, which emphasizes the integration of process development and technical innovation [2] - ST诺泰's main business revenue composition includes 64.98% from active pharmaceutical ingredients and intermediates, 25.48% from CDMO/CMO, 7.00% from formulations, 2.49% from technical service fees, and 0.06% from other sources [8] - The company has received clinical trial approval for its self-developed GLP-1 receptor agonist for diabetes and weight loss, named SPN0103-009 [2] Group 2: Product Approvals - The company’s Thymosin Alpha 1 injection is used for the treatment of chronic hepatitis B [3] - The company has also received approval for Oseltamivir Phosphate capsules, which are antiviral medications for treating and preventing influenza [3] Group 3: Financial Performance - For the period from January to September 2025, ST诺泰 achieved a revenue of 1.527 billion, representing a year-on-year growth of 21.95%, and a net profit attributable to shareholders of 445 million, with a year-on-year increase of 26.92% [8] - The company’s overseas revenue accounted for 63.12% of total revenue, benefiting from the depreciation of the RMB [4] Group 4: Market Activity - The stock has seen a net inflow of 6.44 million in the latest trading session, with a total trading volume of 203 million and a turnover rate of 1.66% [1][5] - The average trading cost of the stock is 42.18, with the current price approaching a resistance level of 39.80, indicating potential for upward movement if this level is surpassed [7]

Core Viewpoint - The company, Zhejiang Yayi Metal Technology Co., Ltd., is experiencing significant growth driven by its focus on outdoor leisure furniture and the expansion of its online sales channels, particularly through cross-border e-commerce platforms [2][4]. Group 1: Company Overview - Zhejiang Yayi Metal Technology Co., Ltd. specializes in the research, design, production, and sales of outdoor leisure furniture, including fire pits and gas stoves, and has developed a comprehensive system for these operations [2][8]. - The company was established on June 9, 2005, and went public on December 22, 2021, with its main revenue sources being fire pits (55.86%), other products (33.74%), and gas stoves (10.40%) [8]. Group 2: Financial Performance - In 2023, the company reported a significant increase in revenue, achieving 296 million yuan, which represents a year-on-year growth of 87.22%, largely attributed to the success of its online sales channels [2]. - For the period from January to September 2025, the company achieved a revenue of 239 million yuan, reflecting a year-on-year increase of 22.23%, while the net profit attributable to the parent company was 1.78 million yuan, a decrease of 68.19% [9]. Group 3: Investment and Partnerships - The company announced on July 26, 2023, its intention to invest 10.2 million yuan in a partnership with several investment firms to establish a venture capital partnership, holding a 39.98% stake [3]. Group 4: Market Position and Strategy - The company has positioned itself as a leading provider of fire pits and gas stoves in China, benefiting from the depreciation of the yuan, which has increased its overseas revenue share to 98.94% [4]. - The company is actively expanding its presence on emerging social e-commerce platforms like TikTok and Wayfair, targeting younger consumers and optimizing logistics through the support of the Zhejiang cross-border e-commerce pilot zone [2].

Core Viewpoint - TCL Smart Home's stock experienced a slight decline of 0.81% on October 24, with a trading volume of 102 million yuan and a total market capitalization of 10.646 billion yuan [1] Group 1: Business Overview - The company's main business includes the research, production, and sales of household refrigerators, freezers, and washing machines [3] - TCL has maintained the position of the largest exporter of refrigerators in China for 14 consecutive years, serving over 130 countries and regions, including those along the Belt and Road Initiative [3] - As of the 2024 annual report, overseas revenue accounted for 73.50% of the company's total revenue, benefiting from the depreciation of the RMB [4] Group 2: Financial Performance - For the first half of 2025, TCL Smart Home achieved a revenue of 9.476 billion yuan, representing a year-on-year growth of 5.74%, and a net profit attributable to shareholders of 638 million yuan, up 14.15% year-on-year [8] - The company has distributed a total of 224 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [9] Group 3: Market Dynamics - The company has engaged in AI voice control and AI intelligent dual-frequency technology, indicating a focus on product intelligence to meet customer demands [4] - The stock's average trading cost is 10.43 yuan, with the current price fluctuating between resistance at 10.13 yuan and support at 9.59 yuan, suggesting potential for range trading [7]

Core Viewpoint - The company, Zhejiang Plade Electric Co., Ltd., is experiencing growth in overseas markets and is benefiting from the depreciation of the RMB, with a significant portion of its revenue coming from international sales. Group 1: Company Overview - Zhejiang Plade Electric Co., Ltd. was established on November 1, 2005, and went public on May 30, 2023. The company specializes in the research, design, production, and sales of electric tools, with 94.85% of its revenue coming from electric tool assemblies [6][7]. - As of June 30, 2025, the company reported a revenue of 461 million yuan, representing a year-on-year growth of 11.98%, and a net profit attributable to shareholders of 45.65 million yuan, up 14.23% year-on-year [7][8]. Group 2: Market Position and Strategy - The company has established its own brand flagship stores on platforms like Amazon, eBay, Taobao, and Tmall, covering overseas markets in North America and Europe [2]. - The company has been recognized as a "specialized and innovative" small giant enterprise, which is a prestigious title in China, indicating strong innovation capabilities and market share [3]. Group 3: Financial Performance and Shareholder Information - The company's overseas revenue accounted for 67.86% of total revenue, benefiting from the depreciation of the RMB [3]. - As of June 30, 2025, the number of shareholders increased by 9.69% to 8,815, with an average of 3,616 circulating shares per person, up 16.26% [6][8]. Group 4: Technical Analysis - The average trading cost of the stock is 27.64 yuan, with the current price near a support level of 27.57 yuan, indicating potential for a rebound if this support holds [5].

Core Viewpoint - The company, Shantou Ultrasonic Instrument Research Institute Co., Ltd., is experiencing growth in the pet economy and medical device sectors, benefiting from the depreciation of the RMB and its recent listing as a new stock under the registration system [2][3]. Company Overview - Shantou Ultrasonic Instrument Research Institute Co., Ltd. specializes in the research, development, production, and sales of medical imaging equipment and industrial non-destructive testing equipment [3][7]. - The company was established on November 15, 1982, and was listed on January 22, 2025 [7]. - The main business revenue composition includes: medical ultrasound 71.16%, industrial ultrasound 17.30%, accessories 5.72%, X-ray 4.56%, and others 1.26% [7]. Financial Performance - For the first half of 2025, the company achieved operating revenue of 184 million yuan, representing a year-on-year growth of 15.00%, and a net profit attributable to the parent company of 68.45 million yuan, up 18.50% year-on-year [8]. - As of June 30, 2025, the company had a shareholder count of 22,300, a decrease of 16.65% from the previous period, with an average of 2,456 circulating shares per person, an increase of 19.98% [8]. Market Activity - On October 23, the company's stock rose by 2.26%, with a trading volume of 64.68 million yuan and a turnover rate of 4.50%, bringing the total market capitalization to 10.657 billion yuan [1]. - The stock has seen a net inflow of 3.62 million yuan from major investors today, accounting for 0.06% of the total, with the industry ranking at 9 out of 131 [4][5]. Product and Innovation - The company showcased its innovative veterinary medical imaging products at the 97th WVC annual conference, engaging with industry experts on the development of animal healthcare [2]. - The company has developed a "Hongyun" system for portable ultrasound and DR devices that utilizes 5G networks for remote image transmission and interaction, enhancing the capabilities of portable devices [2][3].